<DOC>
	<DOC>NCT02399358</DOC>
	<brief_summary>Prospoctive cohort of high-dose cyclophosphamide exposed patients. With active estandardize screening of hyponatremia development in the follow up period.</brief_summary>
	<brief_title>Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide</brief_title>
	<detailed_description>Primary objectives 1. To identify the factors associated with the development of hyponatremia in patients receiving high-dose cyclophosphamide (2.5 grams or more). 2. Generate and validate a predictive score of developing hyponatremia high-dose cyclophosphamide. 3. To estimate the incidence of hyponatremia in patients undergoing high-dose cyclophosphamide. Study design. Observational prospective cohort study of Patients after infusion of high-dose cyclophosphamide. Follow up period will be from cyclophosphamide infusion until one month after hospital discharge.</detailed_description>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Adult patients (over 18 years) who were admitted to the Hematology / Oncology and Medical Clinic Hospital Italiano de Buenos Aires infusion of highdose cyclophosphamide for conducting MSCH prior BMT, GATLA and HyperCVAD in the period 20152017. Refusal to participate or to the process of informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Drug induced Hyponatremia</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Hyponatremia</keyword>
	<keyword>Cyclophosphamide induced Hyponatremia</keyword>
</DOC>